Canine Aβ40 antibody and antigen (recombinant protein)

Diagnostic anti-Canine Aβ40 antibodies pairs and antigen for animal health (animal Dog/Canine Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Companion Animal disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-CAN-AB40-Ag01Canine Aβ40$3090.00
GMP-CAN-AB40-Ab01Anti-Canine Aβ40 mouse monoclonal antibody (mAb)$3090.00
GMP-CAN-AB40-Ab02Anti-Canine Aβ40 mouse monoclonal antibody (mAb)$3090.00
GMP-CAN-AB40-Ab03Anti-Canine Aβ40 human monoclonal antibody (mAb)$3090.00
GMP-CAN-AB40-Ab04Anti-Canine Aβ40 human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-CAN-AB40-Ag01
Product NameCanine Aβ40
Target/BiomarkerCanine Aβ40
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Canine Aβ40 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ40 level test of animal Dog/Canine with Alzheimer Disease(AD).
TagHis
Reconized/Reactive SpecicsCanine Aβ40
Product descriptionRecombinant Canine Aβ40 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-CAN-AB40-Ab01,GMP-CAN-AB40-Ab02
Target/BiomarkerCanine Aβ40
Product NameAnti-Canine Aβ40 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Canine Aβ40 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ40 antibodies in Canine Aβ40 level test of animal Dog/Canine with Alzheimer Disease(AD).
Product descriptionAnti-Canine Aβ40 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ40 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-CAN-AB40-Ab03,GMP-CAN-AB40-Ab04
Target/BiomarkerCanine Aβ40
Product NameAnti-Canine Aβ40 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Canine Aβ40 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ40 antibodies in Canine Aβ40 level test of animal Dog/Canine with Alzheimer Disease(AD).
Product descriptionAnti-Canine Aβ40 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Canine Amyloid-beta 40 (Aβ40) stands as a pivotal molecule in canine neuroscience, assuming a central role in our understanding of neurodegenerative conditions affecting our beloved canine companions. Comprising 40 amino acids, Aβ40 is a fragment of the amyloid precursor protein (APP) and represents a critical component in the formation of amyloid plaques within the canine brain. These plaques, predominantly composed of Aβ40, are emblematic of cognitive decline in dogs, most notably in cases of canine cognitive dysfunction syndrome (CCDS).

    The genesis of Aβ40 involves proteolytic cleavage of APP, a process mediated by β-secretase and γ-secretase enzymes. In dogs afflicted by CCDS, an imbalance in Aβ40 metabolism and clearance results in its aggregation, leading to the accumulation of amyloid plaques. These plaques disrupt normal neural function, contributing substantially to the cognitive deficits and memory impairments observed in affected dogs.

    The implications of Aβ40 aggregation transcend cognitive deficits. Aβ40 aggregates can trigger neuroinflammation, oxidative stress, and synaptic dysfunction, all of which collectively contribute to the progressive neurological decline seen in dogs suffering from CCDS.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.